2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

FDA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis Late last week, the U.S. Food and Drug Administration approved Insmed’s Brinsupri (brensocatib), marking the first approved therapy for non-cystic fibrosis bronchiectasis, a chronic lung condition affecting an estimated 350,000 to 500,000 adults in the United States. The disease is characterized by persistent infection and inflammation in […]